Journal List > Korean J Obstet Gynecol > v.53(5) > 1006408

TOOLS
Kwon and Yoon: Benign gynecologic conditions in pregnancy
Recent Clinical Review
Korean Journal of Obstetrics and Gynecology

Korean Journal of Obstetrics and Gynecology 2010; 53(5): 381-388.

Published online: 31 May 2010

DOI: https://doi.org/10.5468/kjog.2010.53.5.381

Benign gynecologic conditions in pregnancy

Han-Sung Kwon, M.D., Sang-Hee Yoon, M.D.

Department of Obstetrics and Gynecology, Konkuk University School of Medicine, Seoul, Korea.

Corresponding author (a9328011@kuh.ac.kr)

Received 30 December 2009       Accepted 2 February 2010

Copyright © 2010 Korean Society of Obstetrics and Gynecology

Abstract

Gynecologic disease during pregnancy has various effects on and changes by pregnancy according to diagnoses. With recent advancement in diagnostic techniques such as ultrasonography, it makes possible for some disease to diagnose accurately. By predicting complication and treating appropriately, not only treatment but also prognosis can be improved. This study aims to investigate the effect of benign gynecologic disease on pregnancy, diagnosis, and treatment when associated with pregnancy.

Keywords: Pregnancy, Gynecologic disease

Figures and Tables

Fig. 1
Algorithm for the management of the abnormal Pap smear and CIN in pregnancy. (Hunter MI, et al. Am J Obstet Gynecol 2008; 199: 3-9, with permission from Elsevier).22
AGC: atypical glandular cells, AIS: adenocarcinoma-in-situ, ASC-H: favor high grade, ASC-US: atypical squamous intraepithelial lesion of undetermined significance, CIN: cervical intraepithelial neoplasia, HR-HPV: high risk human papillomavirus testing, HSIL: high grade squamous intraepithelial lesion, LSIL: low grade SIL.
kjog-53-381-g001
Table 1
Cervical cancer screening during pregnancy
kjog-53-381-i001

ECC: endocervical curettage, CIN: cervical intraepithelial neoplasia.

Table 2
Recommended regimens for pregnant women: 2006 The Centers for Disease Control and Prevention guidelines
kjog-53-381-i002

References

1. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008. 198:357–366.
2. Neiger R, Sonek JD, Croom CS, Ventolini G. Pregnancy-related changes in the size of uterine leiomyomas. J Reprod Med. 2006. 51:671–674.
3. Aharoni A, Reiter A, Golan D, Paltiely Y, Sharf M. Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study. Br J Obstet Gynaecol. 1988. 95:510–513.
4. Lev-Toaff AS, Coleman BG, Arger PH, Mintz MC, Arenson RL, Toaff ME. Leiomyomas in pregnancy: sonographic study. Radiology. 1987. 164:375–380.
5. Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol. 2006. 22:106–109.
6. Vergani P, Locatelli A, Ghidini A, Andreani M, Sala F, Pezzullo JC. Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol. 2007. 109:410–414.
7. Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol. 2006. 107:376–382.
8. Exacoustos C, Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol. 1993. 82:97–101.
9. Rice JP, Kay HH, Mahony BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 1989. 160:1212–1216.
10. Sheiner E, Bashiri A, Levy A, Hershkovitz R, Katz M, Mazor M. Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas. J Reprod Med. 2004. 49:182–186.
11. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000. 95:764–769.
12. Vergani P, Ghidini A, Strobelt N, Roncaglia N, Locatelli A, Lapinski RH, et al. Do uterine leiomyomas influence pregnancy outcome? Am J Perinatol. 1994. 11:356–358.
13. Davis JL, Ray-Mazumder S, Hobel CJ, Baley K, Sassoon D. Uterine leiomyomas in pregnancy: a prospective study. Obstet Gynecol. 1990. 75:41–44.
14. Roberts WE, Fulp KS, Morrison JC, Martin JN Jr. The impact of leiomyomas on pregnancy. Aust N Z J Obstet Gynaecol. 1999. 39:43–47.
15. De Carolis S, Fatigante G, Ferrazzani S, Trivellini C, De Santis L, Mancuso S, et al. Uterine myomectomy in pregnant women. Fetal Diagn Ther. 2001. 16:116–119.
16. Celik C, Acar A, Cicek N, Gezginc K, Akyurek C. Can myomectomy be performed during pregnancy? Gynecol Obstet Invest. 2002. 53:79–83.
17. Azziz R. Adenomyosis in pregnancy. A review. J Reprod Med. 1986. 31:224–227.
18. Keettel WC. Prolapse of the uterus associated with pregnancy. Am J Obstet Gynecol. 1941. 42:121–126.
19. Kiguchi K, Bibbo M, Hasegawa T, Kurihara S, Tsutsui F, Wied GL. Dysplasia during pregnancy: a cytologic follow-up study. J Reprod Med. 1981. 26:66–72.
20. Lorenzato F, Singer A, Mould T, Santos LC, Maia A, Cariri L. Cervical cancer detection by hybrid capture and evaluation of local risk factors. Int J Gynaecol Obstet. 2001. 73:41–46.
21. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 2000. 82:1332–1338.
22. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol. 2008. 199:3–9.
23. Stillson T, Knight AL, Elswick RK Jr. The effectiveness and safety of two cervical cytologic techniques during pregnancy. J Fam Pract. 1997. 45:159–163.
24. Sato M, Nakamura Y, Sogawa T, Yang Q, Taniguchi T, Taniguchi E, et al. Immunolocalization of glucose transporter 1 and 3 in the placenta: application to cytodiagnosis of Papanicolaou smear. Diagn Cytopathol. 2002. 26:373–379.
25. Pisharodi LR, Jovanoska S. Spectrum of cytologic changes in pregnancy. A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol. 1995. 39:905–908.
26. Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol. 1997. 17:99–107.
27. Levitt C, Shaw E, Wong S, Kaczorowski J, Springate R, Sellors J, et al. Systematic review of the literature on postpartum care: selected contraception methods, postpartum Papanicolaou test, and rubella immunization. Birth. 2004. 31:203–212.
28. Leiserowitz GS, Xing G, Cress R, Brahmbhatt B, Dalrymple JL, Smith LH. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006. 101:315–321.
29. Leiserowitz GS. Managing ovarian masses during pregnancy. Obstet Gynecol Surv. 2006. 61:463–470.
30. Al-Fozan H, Tulandi T. Safety and risks of laparoscopy in pregnancy. Curr Opin Obstet Gynecol. 2002. 14:375–379.
31. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ. 2004. 329:371.
32. Kiss H, Pichler E, Petricevic L, Husslein P. Cost effectiveness of a screen-and-treat program for asymptomatic vaginal infections in pregnancy: towards a significant reduction in the costs of prematurity. Eur J Obstet Gynecol Reprod Biol. 2006. 127:198–203.
33. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008. CD006178.
34. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007. CD000262.
35. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med. 2001. 345:487–493.
36. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al. Rakai Project Study Group. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet. 1999. 353:525–535.
TOOLS
Similar articles